Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2002; 40:1275-1282
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molenaar, P.
Right arrow Articles by Russell, F. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molenaar, P.
Right arrow Articles by Russell, F. D.

Conservation of the cardiostimulant effects of (–)-norepinephrine across Ser49Gly and Gly389Arg beta1-adrenergic receptor polymorphisms in human right atrium in vitro

Peter Molenaar, PhD*,*, Glenn Rabnott, BSc(Hons){dagger}, Ian Yang, MBBS, FRACP{dagger}, Kwun M. Fong, MBBS, PhD, FRACP{dagger}, Santiyagu M. Savarimuthu, MSc{dagger}, Li Li, MD*, Malcolm J. West, MBBS, PhD, FRACP* and Fraser D. Russell, PhD*

* National Heart Foundation and Prince Charles Hospital Foundation Cardiovascular Research Centre, Department of Medicine, University of Queensland, Queensland, Australia
{dagger} Division of Thoracic Medicine, The Prince Charles Hospital, Chermside, Queensland, Australia



View larger version (53K):

[in a new window]
 
Figure 1 Genotyping of the beta1-adrenergic receptor at nucleotide 145 (Ser49Gly) (A) and 1165 (Gly389Arg) (B) in patients undergoing coronary artery bypass grafting from which the right atrium was obtained and used to assess the contractile effects of (–)-norepinephrine at polymorphic beta1-adrenergic receptors. The figure shows polymerase chain reaction fragments of the predicted length after endonuclease digestion to discriminate between patients homozygous for Ser49, Gly49, or heterozygous for Ser49Gly (A) or homozygous for Gly389, Arg389, or heterozygous for Gly389Arg (B). Arg = arginine; bp = base pair; Gly = glycine; Ser = serine.

 


View larger version (35K):

[in a new window]
 
Figure 2 Concentration-dependent effects of (–)-norepinephrine for changes in contractile force, time to reach peak force, and time to reach 50% relaxation (t50) through activation of Ser49Gly- and Gly389Arg-polymorphisms of the beta1-adrenergic receptor in human right atrium. Contractile force is expressed in terms of absolute force (mN). Experiments were completed by incubation of tissues with 200 µM (–)-isoproterenol to maximally stimulate both beta1- and beta2-adrenergic receptors followed by raising the concentration of Ca2+ to 9.25 mM. Values shown are mean ± SEM, where SEM values were determined from each specific –log (–)-norepinephrine concentration. Errors not shown when smaller than symbol. Values in parenthesis show (tissue number/patient number). Arg = arginine; Gly = glycine; Ser = serine.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement